- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 536
Cerevance clears $45m series B
GV and Takeda have backed a series B round that will fund the Rockefeller University spinout's identification of targets for brain disease treatments.
Apr 15, 2020Cerevance clears $45m series B
GV and returning investor Takeda Ventures chipped into a series B round that will fund the identification of targets for brain disease treatments.
Apr 15, 2020SilverCloud sizzles with $16m series B
MemorialCare Innovation Fund led a series B round featuring UnityPoint Health Ventures and OSF Ventures, taking SilverCloud's total funding past $30m.
Apr 15, 2020Corigin Ventures corrals $36m for second fund
Corigin's property and consumer technology-focused venture capital arm has closed its second fund and hired Aubrie Pagano in a partner position.
Apr 15, 2020Daily deal net: April 14, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Apr 14, 2020Bugcrowd bags $30m in series D round
The Salesforce-backed, crowd-focused cybersecurity services provider has now raised $80m altogether, VC firm Rally Ventures leading its latest round.
Apr 14, 2020Daily deal net: April 9, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Apr 9, 2020CVC in the Time of Coronavirus: Jason Miles, VFS Innovation Ventures
Although newly formed, Volvo Financial Services' strategic investment arm is optimstic about the potential of mature technologies meeting more inviting valuations.
Apr 9, 2020Cohesity collects $250m in series E round
HPE, Cisco Investments and SoftBank Vision Fund chipped in as the data management platform developer more than doubled its valuation to $2.5bn.
Apr 9, 2020Keros bosses IPO to raise $96m
Partners Healthcare and Medison Pharma-backed Keros Therapeutics floated at the top of its range and will look to advance its musculoskeletal disorder drug candidates.
Apr 9, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


